Coronavirus Update - 09th November 2020

We would like to reassure our customers that as England enters its second national lockdown period, we remain open for business and at full capacity as we have done since the start of this pandemic and fully comply with all government guidance on minimising the risks of COVID-19.

As the situation continues to evolve, we will keep all our customers and stakeholders informed of our activities through this web-page which is updated on a regular basis.

Contract Pharma: ‘A Modern CDMO’ article

Our Head of Drug Substance, Paul Quigley, recently shared his thoughts on the importance of flexibility, collaboration and innovation for the modern CDMO. In his article for Contract Pharma, Paul explains the greater need for more effective process solutions during drug development and how successful contract service organisations are meeting this challenge. He also defines the Arcinova model for accelerated delivery, through integrated services and technological innovation.
Read the article in ContractPharma




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH